Webwire.com

Medtronic Receives FDA Approval For Interstim® II System For Treatment Of Overactive Bladder, Urinary Retention

Advancements offer choice of devices to accommodate more patients, streamline implant procedure, and simplify programming and follow-up care MINNEAPOLIS – July 5, 2006 – Medtronic, Inc. (NYSE: MDT), ...
Nasdaq

Medtronic Receives CE Mark for InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence InterStim Micro is a ...
irblog.prnewswire.com

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim™ SureScan™ MRI Leads

DUBLIN, Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
Nasdaq

Axonics® Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation ...
Yahoo Finance

FDA Approves Expanded MRI labeling For Medtronic's Sacral Neuromodulation Systems

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
UPI

Medtronic overactive bladder device OK'd

ST. PAUL, Minn., July 5 (UPI) -- Medtronic said Wednesday its InterStim II System for overactive bladder has been approved for the U.S. market. The device -- which includes an implantable ...
Yahoo Finance

Medtronic Expands Leadership in Treating Bladder and Bowel Control Conditions with Two New FDA-Approved Products: InterStim™ Micro Neurostimulator and InterStim™ SureScan ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
FierceBiotech

Medtronic's rechargeable neurostimulator implant nets FDA approval for bladder and bowel control

The InterStim Micro's rechargeable battery gives it an implant life of 15 years, and is 83% smaller than Medtronic's previous InterStim II, which needed to be surgically swapped out every three to ...
Healio

FDA approves expanded labeling for sacral neuromodulation systems with SureScan MRI leads

Please provide your email address to receive an email when new articles are posted on . The FDA approved expanded labeling for Medtronic’s InterStim II and InterStim Micro sacral neuromodulation ...
Stockhouse

Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim(TM) SureScan(TM) MRI Leads

DUBLIN , Feb. 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration ...
Finanznachrichten

Medtronic plc: Medtronic Receives CE Mark for InterStim Micro Neurostimulator and InterStim SureScan MRI Leads

Full-Body MRI-Conditional InterStim II and InterStim Micro Systems Offer Lifestyle-Friendly Choices in Sacral Neuromodulation Therapy to Europeans Suffering from Incontinence DUBLIN, Jan. 13, 2020 ...
Finanznachrichten

Axonics Modulation Technologies, Inc.: Axonics Announces Survey Results of Patients Treated with the Axonics r-SNM System That Were Previously Implanted with InterStim II

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (SNM) devices for the treatment of ...